Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life─threatening infectious diseases,...
Vous n'êtes pas connecté
Scientists at the School of Biosciences and Veterinary Medicine at the University of Camerino (Italy) and CureLab Oncology (Boston) have uncovered the indirect therapeutic potential of Elenagen, a circular DNA encoding the p62/SQSTM1 protein. This discovery offers a new understanding of Elenagen’s recently reported anti-cancer effects and opens exciting possibilities for developing novel therapies for age- and inflammation-related diseases. The two [...]
Aethlon Medical, Inc., a medical therapeutic company focused on developing products to treat cancer and life─threatening infectious diseases,...
Checkpoint inhibitor therapies release the immune system's molecular "brakes," removing protein barriers that hinder its ability to detect and...
Biologics are a cornerstone of modern medicine, offering groundbreaking treatments for a wide range of diseases, including cancer, autoimmune...
Society of Nuclear Medicine and Molecular Imaging Annual Meeting Cleveland Clinic researchers have discovered a new location for a protein that helps...
Raya Therapeutic Inc., (Raya) a mission─driven company focused on the treatment of ALS and other neurodegenerative diseases, announced supportive...
A recent study has illuminated a significant relationship between vitamin B12 levels and chronic inflammation, a culprit behind several severe health...
Competitive: Charles River Laboratories - Scotland: For 75 years, Charles River employees have worked together to assist in the discovery,...
Oncology Drugs Market Oncology is the branch of medicine that includes cancer prevention, diagnosis, treatment, and study. Cancer describes the...
CAMBRIDGE, Mass.--(BUSINESS WIRE) June 28, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced...
CDR─Life Inc, a global company developing powerful T─cell engagers (TCE) to eradicate hard─to─treat solid tumors, has announced an expansion...